Recurrence of the 'deep-intronic' FGG IVS6-320A>T mutation causing quantitative fibrinogen deficiency in the Italian population of Veneto

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 5, 2009, Pages 381-384

  Platè, Manuela ^a   Duga, Stefano ^a   Castaman, Giancarlo ^b   Rodeghiero, Francesco ^b   Asselta, Rosanna ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Common founder; Deep intronic mutation; Fibrinogen; Haplotype analysis; Quantitative fibrinogen deficiency

Indexed keywords

ADULT; AFIBRINOGENEMIA; ARTICLE; BLOOD CLOTTING TEST; FIBRINOGEN DEFECT; GENE CLUSTER; GENE IDENTIFICATION; GENE MUTATION; GENETIC DISORDER; GENETIC SCREENING; GEOGRAPHY; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ADULT; AFIBRINOGENEMIA; CODON, NONSENSE; FIBRINOGENS, ABNORMAL; FOUNDER EFFECT; HAPLOTYPES; HUMANS; INTRONS; ITALY; MALE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 68149120581     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283256024     Document Type: Article

References (21)

1. Asselta R, Duga S, Tenchini ML. The molecular basis of quantitative fibrinogen disorders. J Thromb Haemost 2006; 4:2115-2129.
2. Neerman-Arbez M, de Moerloose P. Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations. Hum Mutat 2007; 28:540-553.
3. Monaldini L, Asselta R, Duga S, Peyvandi F, Karimi M, Malcovati M, Tenchini ML. Mutational screening of six afibrinogenemic patients: identification and characterization of four novel molecular defects. Thromb Haemost 2007; 97:546-551.
4. Platè M, Asselta R, Peyvandi F, Tenchini ML, Duga S. Molecular characterization of the first missense mutation in the fibrinogen Aalpha-chain gene identified in a compound heterozygous afibrinogenemic patient. Biochim Biophys Acta 2007; 1772:781-787.
5. Spena S, Asselta R, Platè M, Castaman G, Duga S, Tenchini ML. Pseudo-exon activation caused by a deep-intronic mutation in the fibrinogen γ-chain gene as a novel mechanism for congenital afibrinogenaemia.Br J Haematol 2007; 139:128-132.
6. Hanss M, Chevreaud C, French P,NégrierC,de Mazancourt P.Clinical and biological features of 3 cases of hypofibrinogenemia associated with three different mutations (gamma Ala341Thr, Bbeta Tyr326Cys and Aalpha Asp496Asn). Thromb Haemost 2007; 98:689-691.
7. Davis RL, Brennan SO. Fibrinogen Tolaga Bay: a novel gammaAla341Val mutation causing hypofibrinogenaemia. Thromb Haemost 2007; 98:1136-1138.
8. Davis RL, Mosesson MW, Kerlin BA, Canner JA, Ruymann FB, Brennan SO. Fibrinogen Columbus: a novel gamma Gly200Val mutation causing hypofibrinogenemia in a family with associated thrombophilia. Haematologica 2007; 92:1151-1152.
9. Angles-Cano E, Mathonnet F, Dreyfus M, Claeyssens S, de Mazancourt P. A case of afibrinogenemia associated with A-alpha chain gene compound heterozygosity (HUMFIBRA c. [4110delA]+[3200+1G>T]). Blood Coagul Fibrinolysis 2007; 18:73-75.
10. Fang Y, Dai BT, Wang XF, Fu QH, Dai J, Xie F, et al. Identification of three FGA mutations in two Chinese families with congenital afibrinogenaemia. Haemophilia 2006; 12:615-620.
11. Platè M, Asselta R, Spena S, Spreafico M, Fagoonee S, Peyvandi F, et al. Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion. Blood Cell Mol Dis 2008; 41:292-297.
12. Neerman-Arbez M, de Moerloose P, Bridel C, Honsberger A, Schonborner A, Rossier C, et al. Mutations in the fibrinogen alpha gene account for the majority of cases of congenital afibrinogenemia. Blood 2000; 96:149-152.
13. Neerman-Arbez M, de Moerloose P, Honsberger A, Parlier G, Arnuti B, Biron C, et al. Molecular analysis of the fibrinogen gene cluster in
14. patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes. Hum Genet 2001; 108:237-240.
15. Okumura N, Terasawa F, Yonekawa O, Hamada E, Kaneko H. Hypofibrinogenemia associated with a heterozygous C>T nucleotide substitution at position -1138 BP of the 5′-flanking region of the fibrinogen A alpha-chain gene. Ann N Y Acad Sci 2001; 936:526-530.
16. Dear A, Daly J, Brennan SO, Tuckfield A, George PM. An intronic mutation within FGB (IVS1+2076 a->) is associated with afibrinogenemia and recurrent transient ischemic attacks. J Thromb Haemost 2006; 4:471-472.
17. Humphries SE, Imam AM, Robbins TP, Cook M, Carritt B, Ingle C, et al. The identification of a DNA polymorphism of the alpha fibrinogen gene, and the regional assignment of the human fibrinogen genes to 4q26-qter. Hum Genet 1984; 68:148-153.
18. Mills KA, Even D, Murray JC. Tetranucleotide repeat polymorphism at the human alpha fibrinogen locus (FGA). Hum Mol Genet 1992; 1:779.
19. Rabe F, Salomon E. Über-faserstoffmangel in Blute bei einem Falle von Haemophilie. Arch Int Med 1920; 95:2.
20. Asselta R, Duga S, Spena S, Santagostino E, Peyvandi F, Piseddu G, et al. Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen A alpha-chain gene are not associated with the decay of the mutant mRNAs. Blood 2001; 98:3685-3692.
21. Fellowes AP, Brennan SO, Holme R, Stormorken H, Brosstad FR, George PM. Homozygous truncation of the fibrinogen A alpha chain within the coiled coil causes congenital afibrinogenemia. Blood 2000; 96:773-775.